Blood and Blood Components Market Size, Share, Growth, and Industry Analysis, By Type (Whole Blood, Blood Components), By Application (Hospitals, Ambulatory Surgical Centers, Others), Regional Insights and Forecast to 2035

Blood and Blood Components Market Overview

Blood and Blood Components Market size is anticipated to be valued at USD 38989.68 million in 2026, with a projected growth to USD 61965.93 million by 2035 at a CAGR of 5.29%.

The Blood and Blood Components Market is witnessing substantial expansion due to increasing surgical procedures, rising prevalence of hematological disorders, and growing demand for plasma-derived therapies across hospitals, trauma centers, and specialty clinics. The market includes whole blood, red blood cells, plasma, platelets, cryoprecipitate, and granulocytes used for transfusion and therapeutic applications. More than 118 million blood donations are collected globally every year, while nearly 40% of these donations are utilized for emergency surgeries and trauma care. Approximately 25% of blood component utilization is linked to cancer therapies and chemotherapy-associated transfusions. Platelet demand has increased by over 18% due to rising incidences of leukemia and bone marrow disorders. Plasma collection centers have expanded by more than 22% globally due to increasing immunoglobulin and albumin requirements. The Blood and Blood Components Market Report highlights strong hospital procurement trends, advanced blood screening technologies, and increasing adoption of pathogen reduction systems, strengthening the Blood and Blood Components Industry Analysis and Market Outlook.

The United States Blood and Blood Components Market remains one of the most advanced healthcare transfusion ecosystems globally. More than 13 million units of whole blood and red blood cells are collected annually across the country, while nearly 29,000 units of red blood cells are required every day in U.S. healthcare facilities. Approximately 16 million blood components are transfused annually, with platelets accounting for nearly 30% of transfusions in cancer treatment centers. Plasma donation centers across the U.S. increased by more than 20% in recent years due to rising demand for immunotherapy products. Around 45% of trauma patients admitted to emergency units require immediate blood transfusion support. Advanced nucleic acid testing technologies are utilized in over 92% of blood banks across the country to improve transfusion safety. The Blood and Blood Components Market Research Report indicates increasing investments in blood storage systems, donor screening technologies, and automated blood collection infrastructure throughout the United States healthcare sector.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 62% of global blood utilization is associated with surgical procedures and emergency trauma cases, while platelet demand has increased by 18% due to hematological disorders and cancer treatment requirements in tertiary healthcare facilities.
• Major Market Restraint: Approximately 28% of low-income healthcare regions face blood shortages, while nearly 35% of collected blood units are affected by storage limitations, transportation inefficiencies, and donor eligibility restrictions across regional blood banks.
• Emerging Trends: Around 48% of hospitals are integrating automated blood component separation technologies, while pathogen reduction adoption has increased by 31% across developed healthcare systems to improve transfusion safety and operational efficiency.
• Regional Leadership: North America accounts for nearly 41% of advanced blood screening implementation, while Europe contributes approximately 34% of plasma collection activities due to strong healthcare infrastructure and organized donor networks.
• Competitive Landscape: More than 52% of blood collection organizations are investing in automated screening systems, while partnerships between hospitals and plasma collection centers increased by 27% to strengthen transfusion supply chains globally.
• Market Segmentation: Blood components contribute nearly 74% of transfusion demand globally, while plasma-derived products account for approximately 36% of therapeutic applications due to increasing chronic disease management and surgical interventions.
• Recent Development: Automated blood storage monitoring systems witnessed adoption growth of 33%, while mobile blood donation campaigns increased donor participation by nearly 26% across urban healthcare networks and institutional donation programs.

Blood and Blood Components Market Latest Trends

The Blood and Blood Components Market Trends indicate rapid technological advancement in blood processing, collection, testing, and storage systems. Automated blood collection devices are now utilized in more than 58% of major healthcare institutions to improve donor efficiency and reduce contamination risks. Pathogen reduction technologies have witnessed adoption growth exceeding 30%, particularly in platelet and plasma processing applications. Nearly 46% of hospitals are implementing digital blood inventory management systems to minimize wastage and optimize transfusion workflows. Mobile blood donation units increased by approximately 24%, improving blood accessibility in rural and semi-urban regions. Artificial intelligence-assisted donor screening systems are being deployed across advanced blood banks to reduce screening errors by nearly 19%. Plasma-derived therapies are witnessing increasing demand due to rising autoimmune disorders, with immunoglobulin utilization increasing by more than 21%. Blood component separation technologies are now preferred in over 68% of transfusion centers because they improve utilization efficiency and reduce unnecessary whole blood transfusions. The Blood and Blood Components Market Analysis also highlights increasing investments in cold chain transportation systems, with advanced storage solutions reducing blood spoilage rates by approximately 17% globally.

Blood and Blood Components Market Dynamics

DRIVER

"Increasing Demand for Trauma and Surgical Transfusions"

The growing number of surgical procedures, accident-related injuries, and chronic disease treatments is significantly accelerating demand within the Blood and Blood Components Market. More than 310 million major surgeries are conducted globally every year, with approximately 35% requiring blood transfusion support during operative procedures. Trauma-related emergency admissions account for nearly 40% of red blood cell utilization across urban hospitals. Cardiovascular surgeries contribute approximately 22% of platelet and plasma demand in advanced healthcare systems. Rising cancer incidence has increased platelet transfusion requirements by more than 18%, especially among leukemia and chemotherapy patients. Around 28% of intensive care unit admissions require immediate blood component therapy for stabilization and organ support. Hospitals are increasingly prioritizing component therapy instead of whole blood transfusions, improving transfusion efficiency by nearly 26%. Government-sponsored blood donation awareness programs have increased donor registrations by approximately 20% in metropolitan regions. The Blood and Blood Components Market Growth is further supported by expanding healthcare infrastructure, increasing emergency response capabilities, and higher demand for plasma-based therapies in chronic disease management.

RESTRAINTS

"Short Shelf Life and Blood Storage Limitations"

Storage constraints and limited shelf life remain significant challenges affecting the Blood and Blood Components Market Outlook. Platelets generally have a storage life of only five to seven days, resulting in nearly 12% wastage rates across healthcare facilities. Red blood cells can typically be stored for approximately 42 days, while plasma storage requires highly controlled freezing infrastructure, increasing operational complexity. Around 30% of regional blood banks in developing economies face cold chain transportation limitations, reducing blood accessibility during emergencies. Donor deferral rates have increased by approximately 15% due to stricter screening protocols and infection-related concerns. Seasonal fluctuations in donation rates reduce blood availability by nearly 18% during public health emergencies and pandemic outbreaks. Blood screening compliance requirements have also increased operational expenditures for blood collection centers. Approximately 22% of healthcare institutions report periodic shortages in rare blood groups due to insufficient donor pools. The Blood and Blood Components Industry Report identifies inventory imbalance, refrigeration costs, and component expiration issues as critical operational barriers impacting supply chain consistency and transfusion management.

OPPORTUNITY

"Expansion of Plasma-Derived Therapeutics"

The increasing use of plasma-derived therapies presents substantial opportunities within the Blood and Blood Components Market Opportunities landscape. Plasma utilization has increased by more than 24% due to growing treatment demand for autoimmune disorders, hemophilia, neurological diseases, and immunodeficiency conditions. Immunoglobulin therapies now account for approximately 38% of plasma fractionation applications globally. More than 50% of advanced plasma collection centers are expanding automated plasmapheresis systems to improve collection efficiency and donor retention. Specialty biologic therapies derived from plasma are witnessing increasing adoption in tertiary healthcare institutions and specialty clinics. Emerging healthcare economies are expanding plasma collection infrastructure by nearly 20% to reduce dependence on imported plasma products. Mobile plasma donation technologies have increased donor accessibility by approximately 17% across urban healthcare systems. Research activities related to recombinant plasma proteins and advanced fractionation technologies are also strengthening innovation across the Blood and Blood Components Market Research Report. Public-private healthcare partnerships are supporting investment in plasma logistics, screening systems, and donor awareness initiatives, enabling improved therapeutic accessibility and long-term market expansion.

CHALLENGE

"Risk of Transfusion-Transmitted Infections"

Maintaining transfusion safety remains a major challenge for participants operating in the Blood and Blood Components Market. Despite advancements in blood screening technologies, transfusion-transmitted infections continue to create regulatory and operational concerns across healthcare systems. Approximately 8% of blood collection centers in low-resource regions still face limitations in advanced nucleic acid testing capabilities. Viral contamination risks associated with hepatitis and other infectious diseases continue to influence donor screening procedures globally. Nearly 14% of blood donations require additional laboratory testing due to incomplete screening compliance. Regulatory agencies have increased blood safety monitoring requirements by over 20%, raising operational complexities for blood banks and transfusion centers. Shortages of trained laboratory professionals further affect blood testing efficiency in several developing healthcare markets. In addition, maintaining temperature-controlled transportation for plasma and platelet products remains difficult in remote healthcare regions. The Blood and Blood Components Market Forecast indicates that investment in advanced pathogen reduction technologies, AI-based donor screening systems, and digital blood tracking solutions will remain essential to address long-term transfusion safety concerns.

Blood and Blood Components Market Segmentation

The Blood and Blood Components Market Segmentation is categorized based on type and application, with increasing demand for blood component therapy across hospitals, surgical centers, trauma units, and specialty healthcare facilities. Blood components account for a larger proportion of transfusion procedures due to targeted therapeutic efficiency and reduced transfusion-related complications. Increasing utilization of plasma, platelets, and red blood cells for cancer treatment, trauma management, and chronic disease care continues to strengthen segmental growth. Technological advancements in blood separation systems and donor screening infrastructure are further supporting segmentation expansion across global healthcare systems.

Download FREE Sample to learn more about this report.

BY TYPE

Whole Blood: Whole blood continues to play a critical role in emergency trauma management, military medicine, disaster response, and acute blood loss treatment applications. Approximately 32% of emergency trauma interventions still utilize whole blood transfusions due to immediate oxygen-carrying and volume replacement requirements. Military healthcare systems report nearly 40% utilization of whole blood during battlefield medical procedures because of faster transfusion efficiency. Rural healthcare facilities and emergency medical transport systems also rely heavily on whole blood due to limited component separation infrastructure. Around 26% of accident-related emergency admissions require rapid whole blood transfusion support within the first few hours of hospitalization. Blood donation drives focused on universal donor blood groups have increased by approximately 18% to support emergency preparedness initiatives. Advanced storage systems have improved whole blood preservation efficiency by nearly 14% in modern blood banks. The Blood and Blood Components Market Analysis highlights increasing government investments in emergency transfusion preparedness programs and rapid response healthcare infrastructure to improve whole blood availability during natural disasters, road accidents, and critical care interventions.

Blood Components: Blood components dominate transfusion practices due to their targeted therapeutic applications and efficient utilization across healthcare settings. Nearly 74% of all transfusions globally involve separated blood components such as red blood cells, plasma, platelets, and cryoprecipitate. Red blood cells account for approximately 45% of component transfusion demand, primarily associated with surgeries, trauma care, and anemia treatment. Platelet utilization has increased by over 18% because of rising leukemia, cancer, and bone marrow disorder cases. Plasma-derived therapies are witnessing growing demand, with immunoglobulin usage increasing by approximately 21% in autoimmune disease management. Component therapy reduces unnecessary transfusion exposure by nearly 28%, improving patient safety and resource optimization. Automated blood separation technologies are now implemented in more than 60% of advanced blood banks, increasing processing efficiency and reducing contamination risks. The Blood and Blood Components Industry Analysis indicates that hospitals increasingly prefer component therapy because it enables customized patient treatment, minimizes transfusion complications, and improves blood inventory management across healthcare institutions.

BY APPLICATION

Hospitals: Hospitals represent the largest application segment within the Blood and Blood Components Market due to the high volume of surgeries, emergency treatments, trauma care procedures, and chronic disease management services performed across healthcare systems. Nearly 68% of total blood transfusions globally are conducted within hospital settings because of advanced surgical infrastructure and critical care requirements. Approximately 42% of intensive care unit patients require red blood cell transfusions during hospitalization. Cancer treatment departments within hospitals account for nearly 31% of platelet transfusion demand due to chemotherapy-induced thrombocytopenia. Cardiovascular surgeries contribute around 24% of plasma and blood component utilization in tertiary hospitals. More than 55% of hospitals worldwide have integrated automated blood inventory systems to improve storage efficiency and reduce wastage. Emergency departments report approximately 38% utilization of whole blood transfusions for trauma stabilization and accident-related admissions. In developed healthcare systems, over 85% of hospitals utilize nucleic acid testing for blood screening to enhance transfusion safety. The Blood and Blood Components Market Insights indicate increasing investments in hospital blood banks, advanced refrigeration systems, and digital transfusion monitoring technologies to improve patient outcomes and operational efficiency.

Ambulatory Surgical Centers: Ambulatory Surgical Centers are increasingly contributing to the Blood and Blood Components Market Growth due to the rising number of minimally invasive surgeries and same-day medical procedures. Approximately 27% of outpatient surgical interventions now require blood component availability for emergency support and perioperative management. Orthopedic surgeries performed in ambulatory surgical centers contribute nearly 19% of blood component utilization in outpatient settings. Platelet and plasma demand has increased by approximately 16% in these facilities because of enhanced surgical capabilities and expansion of specialty treatment centers. More than 48% of ambulatory surgical centers have adopted compact blood storage and rapid transfusion systems to improve patient safety during outpatient procedures. Same-day surgical admissions have increased by nearly 21%, supporting the need for reliable blood component access within ambulatory healthcare environments. Automated transfusion compatibility testing systems are implemented in approximately 34% of advanced outpatient surgical facilities. The Blood and Blood Components Market Research Report highlights that ambulatory surgical centers are strengthening partnerships with regional blood banks to improve transfusion readiness, reduce supply delays, and enhance procedural efficiency during elective and emergency outpatient surgeries.

Others: The “Others” application segment includes specialty clinics, military healthcare units, emergency response systems, dialysis centers, and research institutions utilizing blood and blood components for various medical and therapeutic purposes. Approximately 18% of plasma-derived therapy administration occurs within specialty treatment centers managing autoimmune and neurological disorders. Dialysis centers account for nearly 12% of red blood cell transfusion demand due to chronic anemia management among renal disease patients. Military medical units report approximately 15% utilization of whole blood transfusions during field-based emergency interventions and disaster response operations. Mobile healthcare systems and emergency rescue services have expanded blood storage adoption by nearly 20% to improve pre-hospital trauma care. Research laboratories and biotechnology institutions are increasingly utilizing plasma and blood derivatives for immunological and regenerative medicine studies. Around 25% of specialty healthcare centers now use digital blood tracking technologies to enhance transfusion monitoring and reduce procedural risks. The Blood and Blood Components Industry Analysis indicates growing demand across non-traditional healthcare settings due to expanding therapeutic applications, rising emergency preparedness initiatives, and increasing adoption of advanced blood preservation technologies.

Blood and Blood Components Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America dominates the Blood and Blood Components Market due to advanced healthcare infrastructure, high voluntary blood donation rates, and extensive implementation of blood safety technologies. More than 40% of advanced blood screening systems globally are utilized across North American healthcare facilities. Approximately 16 million blood components are transfused annually throughout the region, with red blood cells accounting for nearly 48% of transfusion demand. Platelet utilization has increased by around 20% because of rising cancer treatment procedures and bone marrow disorder management. Over 90% of blood banks in the region utilize nucleic acid testing technologies to enhance donor screening efficiency and transfusion safety. Plasma collection activities have expanded by approximately 24% due to increasing demand for immunoglobulin therapies and specialty biologics. Mobile donation campaigns have improved donor participation rates by nearly 18% in metropolitan areas. Around 60% of hospitals across North America have implemented automated blood inventory systems to reduce wastage and optimize transfusion workflows. The Blood and Blood Components Market Forecast highlights continued technological innovation, increased emergency care utilization, and strong healthcare investments supporting regional market expansion.

Europe

Europe represents a major contributor to the Blood and Blood Components Market, supported by organized healthcare systems, high blood donation awareness, and expanding plasma fractionation capabilities. Nearly 34% of global plasma collection activities are concentrated within European healthcare networks. Voluntary blood donation participation exceeds 50% in several European countries due to government-supported donor awareness initiatives and public healthcare integration. Approximately 44% of blood component demand in Europe is associated with surgical procedures and trauma management. Platelet transfusions have increased by around 17% because of growing hematological disorder cases and expanding oncology treatment programs. More than 70% of regional blood banks utilize automated blood separation technologies to improve processing efficiency and reduce contamination risks. Blood storage modernization projects have reduced spoilage rates by nearly 15% across major healthcare institutions. Plasma-derived therapies account for approximately 29% of specialty biologic treatment applications within Europe. The Blood and Blood Components Market Outlook indicates increasing adoption of pathogen reduction systems, digital transfusion monitoring, and advanced donor screening protocols across regional healthcare systems.

Asia-Pacific

Asia-Pacific is witnessing rapid growth in the Blood and Blood Components Market due to expanding healthcare infrastructure, rising accident rates, and increasing prevalence of chronic diseases. Approximately 45% of the global population resides within the region, contributing significantly to rising blood transfusion demand. Surgical procedures across Asia-Pacific have increased by nearly 23%, supporting higher utilization of blood components in hospitals and trauma centers. Plasma collection activities have expanded by around 19% due to growing demand for immunoglobulin therapies and biologic treatments. Government-led blood donation campaigns have improved donor participation by approximately 21% across urban healthcare networks. More than 52% of tertiary hospitals in developed Asia-Pacific economies now utilize automated blood screening systems. Emergency trauma admissions contribute nearly 35% of red blood cell utilization in major metropolitan healthcare centers. Rising cancer prevalence has increased platelet transfusion requirements by approximately 18% throughout the region. The Blood and Blood Components Market Opportunities in Asia-Pacific are further strengthened by investments in healthcare digitization, expansion of blood bank infrastructure, and increasing adoption of advanced refrigeration and storage technologies.

Middle East & Africa

The Middle East & Africa Blood and Blood Components Market is expanding steadily due to increasing healthcare investments, rising trauma cases, and improving blood donation awareness initiatives. Emergency care admissions contribute nearly 39% of blood transfusion demand across the region due to road accidents, surgical interventions, and critical care procedures. Blood donation campaigns organized by healthcare authorities have increased voluntary donor participation by approximately 16% in urban areas. Around 28% of hospitals across the region are upgrading blood storage and refrigeration infrastructure to improve transfusion safety and reduce wastage. Plasma utilization has increased by nearly 14% due to growing treatment demand for chronic diseases and immunological disorders. More than 30% of tertiary healthcare facilities are implementing automated blood screening systems to strengthen donor safety compliance. Mobile blood donation units are expanding rapidly, improving blood accessibility in underserved communities and remote healthcare regions. Platelet demand has increased by approximately 13% because of rising oncology and hematology treatment activities. The Blood and Blood Components Market Trends indicate continued expansion in regional healthcare infrastructure, stronger public health awareness, and growing investment in blood collection logistics and emergency transfusion preparedness systems.

List of Key Blood and Blood Components Market Companies

• American Red Cross
• Australian Red Cross Blood Service
• Abbott Laboratories
• Blood Centers of America
• Becton, Dickinson & Co.
• Grifols S.A.
• CSL Plasma
• Bio-Rad Laboratories
• Fresenius Kabi
• Haemonetics Corporation

Top Companies with Highest Market Share

• American Red Cross: Handles approximately 40% of blood collection activities across the United States and supports nearly 2,500 hospitals nationwide through advanced blood screening, mobile donation units, and emergency transfusion logistics infrastructure.
• Grifols S.A.: Accounts for nearly 18% of global plasma collection operations and operates extensive plasma donation networks, with automated plasmapheresis technologies improving plasma collection efficiency by approximately 22% across major healthcare markets.

Investment Analysis and Opportunities

The Blood and Blood Components Market is attracting significant investments due to increasing demand for advanced transfusion services, plasma-derived therapies, and automated blood processing systems. More than 48% of healthcare institutions are investing in digital blood inventory platforms to reduce wastage and improve transfusion tracking efficiency. Investments in pathogen reduction technologies have increased by approximately 26% due to rising emphasis on transfusion safety and infection prevention. Automated blood collection infrastructure adoption has expanded by nearly 32% across developed healthcare systems. Plasma collection centers are increasing operational capacity by approximately 20% to support rising immunoglobulin and specialty biologic therapy demand. Around 38% of hospitals are prioritizing investments in smart refrigeration and cold chain transportation systems to improve blood storage performance. Public-private partnerships focused on voluntary blood donation awareness have increased by nearly 18%, strengthening donor availability and emergency preparedness programs. Research investment in recombinant plasma proteins and AI-based donor screening systems continues to create strong market opportunities. The Blood and Blood Components Market Insights indicate that modernization of blood banking infrastructure and expansion of specialty plasma therapeutics will remain key investment priorities globally.

New Products Development

The Blood and Blood Components Market is experiencing substantial innovation in blood safety systems, plasma therapies, storage technologies, and automated collection devices. More than 35% of blood banks are adopting next-generation pathogen reduction systems designed to minimize transfusion-transmitted infection risks. Smart blood bags equipped with digital monitoring sensors have improved storage tracking efficiency by approximately 21%. Automated plasmapheresis systems introduced in modern collection centers have increased plasma collection efficiency by nearly 24%. Portable blood refrigeration units developed for emergency and military healthcare applications are reducing spoilage rates by around 16% during transportation. Advanced blood typing analyzers utilizing artificial intelligence have improved donor compatibility testing accuracy by approximately 19%. New platelet preservation technologies extending storage duration are being introduced across tertiary healthcare systems to reduce inventory shortages. Nearly 28% of hospitals are integrating cloud-based transfusion management platforms to optimize blood utilization workflows. The Blood and Blood Components Market Research Report highlights increasing innovation in biologic plasma therapies, digital donor management systems, and mobile blood collection technologies supporting long-term market advancement.

Five Recent Developments(2023-2025)

• Advanced Plasma Collection Expansion: In 2024, multiple healthcare organizations expanded automated plasma collection infrastructure, increasing plasma processing efficiency by approximately 23%. New automated plasmapheresis systems reduced donor waiting times by nearly 18% while improving collection consistency across large-scale blood donation centers.
• AI-Based Blood Screening Systems: During 2024, artificial intelligence-supported blood screening technologies were introduced across major blood banks, improving donor screening accuracy by around 20%. Automated infection detection systems reduced manual processing errors by approximately 15% in large healthcare facilities.
• Pathogen Reduction Technology Adoption: In 2023, adoption of pathogen reduction systems increased by nearly 28% in platelet and plasma processing centers. Hospitals implementing these systems reported approximately 17% improvement in transfusion safety compliance and reduced contamination risks.
• Mobile Blood Donation Programs: In 2025, mobile blood donation campaigns expanded significantly across urban and semi-urban regions, increasing voluntary donor participation by approximately 21%. Digital donor scheduling systems improved appointment efficiency by nearly 14% during regional blood donation drives.
• Smart Blood Storage Solutions: In 2024, advanced smart refrigeration systems equipped with temperature monitoring sensors were implemented in blood banks, reducing blood spoilage rates by approximately 16%. Automated inventory tracking systems improved blood component availability and reduced emergency supply shortages.

Report Coverage Of Blood and Blood Components Market

The Blood and Blood Components Market Report provides comprehensive analysis of blood collection, transfusion services, plasma therapies, and blood safety technologies across major healthcare systems worldwide. The report evaluates critical market factors including blood donation trends, component utilization patterns, storage technologies, donor screening advancements, and plasma fractionation activities. Approximately 74% of transfusion procedures globally now involve separated blood components, highlighting the increasing preference for targeted therapeutic approaches. The study analyzes technological developments such as automated blood processing systems, AI-based donor screening, digital inventory management, and pathogen reduction technologies influencing operational efficiency and transfusion safety.

The Blood and Blood Co